Stocksigma LogoStocksigma Logo

Supriya Lifescience Ltd - Financial Result for the Quarter ended 30th Sep'26 (Standalone, INR Million)

■ Revenue: 2,063 (+3.2% YoY | +8.7% QoQ) ■ EBITDA: 454 (-37.5% YoY | -4.3% QoQ) ■ EBITDA Margin (%): 22.0 (-1435 bps YoY | -300 bps QoQ) ■ PAT: 293 (-42.0%

Supriya Lifescience Ltd - Financial Result for the Quarter ended 30th Sep'26 (Standalone, INR Million)

Supriya Lifescience Ltd · Outcome · 06 Nov 2026, 6:20 pm

Supriya Lifescience Ltd - Financial Result for the Quarter ended 30th Sep'26 (Standalone, INR Million) ■ Revenue: 2,063 (+3.2% YoY | +8.7% QoQ) ■ EBITDA: 454 (-37.5% YoY | -4.3% QoQ) ■ EBITDA Margin (%): 22.0 (-1435 bps YoY | -300 bps QoQ) ■ PAT: 293 (-42.0% YoY | +21.7% QoQ) ■ EPS (INR): 3.63 (-42.1% YoY | +21.4% QoQ)

Original exchange filing (PDF)

More announcements from Supriya Lifescience Ltd

All Supriya Lifescience Ltd announcements